Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
4
Apple
AAPL
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
TELO Telomir Pharmaceuticals
- 4.020
- 0.0000.00%
Trading Mar 28 09:30 ET
119.65MMarket Cap-7.24P/E (TTM)
4.020High4.020Low1.46KVolume4.020Open4.020Pre Close5.85KTurnover0.01%Turnover RatioLossP/E (Static)29.76MShares9.39052wk High182.73P/B70.21MFloat Cap3.11052wk Low--Dividend TTM17.46MShs Float20.720Historical High--Div YieldTTM0.00%Amplitude3.110Historical Low4.020Avg Price1Lot Size
Telomir Pharmaceuticals News
Telomir Pharmaceuticals Announces Preclinical Findings on Telomir-1
Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells
Express News | Telomir Pharmaceuticals Says 'Telomir-1 Alone at Both Low and High Doses Reduced Tumor Growth by Approximately 50%'
Express News | Telomir Pharmaceuticals Says 'Telomir-1 Inhibits Tumor Growth, Suppresses Cancer Progression, and Neutralizes Chemotherapy Toxicity'
Telomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study Shows
Express News | Telomir Pharmaceuticals - Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model
Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines
Express News | Telomir Pharmaceuticals Inc - Telomir-1 Reverses Calcium Dysregulation in Multiple Human Cell Lines
Rodman & Renshaw Initiates Telomir Pharmaceuticals(TELO.US) With Buy Rating, Announces Target Price $15
Telomir Pharmaceuticals Initiated With a Buy at Rodman & Renshaw
Express News | Telomir Pharmaceuticals Achieves Breakthrough In Silver Ion Stabilization, Says Unlocking A New Multi-Billion Dollar Medical Market
Telomir Pharmaceuticals Seeks To Tap Multi-Billion-Dollar Market With Breakthrough In Silver Ion Stabilization For Antibacterial Treatment, Tissue Regeneration
Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)
Express News | Telomir Pharmaceuticals Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing
Telomir Pharmaceuticals | 10-K: FY2024 Annual Report
Telomir Pharmaceuticals Announces Results From Preclinical Studies of Telomir-1
Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses
Express News | Telomir Pharmaceuticals Inc - Telomir-1 Reverses Copper-Induced Ros Elevation in Human Cell Lines
Express News | Telomir Pharmaceuticals Inc - Announces Breakthrough Results With Telomir-1
Telomir Touts Potential of Telomir-1 in Addressing Oxidative Stress
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call